global antibody conjugates drugs market 2016 - 2020

11
www.MarketResearchReports.com Global Antibody Conjugates Drugs Market 2016-2020 Category : Drug Delivery All logos and Images mentioned on this slide belong to their respective owners.

Upload: market-research-reports-inc

Post on 14-Apr-2017

191 views

Category:

Health & Medicine


0 download

TRANSCRIPT

Page 1: Global Antibody Conjugates Drugs Market 2016 - 2020

www.MarketResearchReports.com

Global Antibody

Conjugates Drugs Market

2016-2020

Category : Drug Delivery

All logos and Images mentioned on this slide belong to their respective owners.

Page 2: Global Antibody Conjugates Drugs Market 2016 - 2020

www.MarketResearchReports.com

Introduction to Report

Launch Date: March 31, 2016

Number of Pages: 75

Geography Coverage: Global

Available Format: PDF

Price For Single User License: USD 2,500

Price For Site User License: USD 4,000

Price For Global User License: USD 10,000

Delivery Time: Within 24 Hours (During Working Days)

Page 3: Global Antibody Conjugates Drugs Market 2016 - 2020

www.MarketResearchReports.com

About the Report

Global Antibody Drug Conjugates Market to grow at a CAGR of 41.58% during the period 2016-2020.

This report has been prepared based on an in-depth market analysis with inputs from industry experts.

The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Page 4: Global Antibody Conjugates Drugs Market 2016 - 2020

www.MarketResearchReports.com

Key Highlights:

Antibody Drug Conjugates, empowered monoclonal antibodies (mAbs), use chemical linkers with labile bonds to attach biologically active substances.

ADCs target mAbs with the cancer killing ability of cytotoxic drugs, allowing sensitive discernment between healthy and diseased tissue.

Antibodies are the proteins produced by B-cells (from bone marrow) in the immune system.

These proteins attach to antigens, which act as markers, and are then destroyed by phagocytes.

B-cells produce different antibodies that attach to different sites of an antigen.

mAbs, complex proteins with high molecular weight, are monospecific as they are the clones of a single parent cell.

Page 5: Global Antibody Conjugates Drugs Market 2016 - 2020

www.MarketResearchReports.com

Key Highlights: Continues…

They are of three types, chimeric, humanized, and fully human, and are often used for therapeutic and diagnostic purposes.

The report covers the present scenario and the growth prospects of the global ADCs market for the period 2015-2020.

To calculate the market size, the report considers revenue generated from the sales of ADCs used to treat cancer.

Page 6: Global Antibody Conjugates Drugs Market 2016 - 2020

www.MarketResearchReports.com

Key Questions Answered in this Report

What will the market size be in 2020 and what will the growth rate be?

What are the key market trends?

What is driving this market?

What are the challenges to market growth?

Who are the key vendors in this market space?

What are the market opportunities and threats faced by the key vendors?

What are the strengths and weaknesses of the key vendors?

Page 7: Global Antibody Conjugates Drugs Market 2016 - 2020

www.MarketResearchReports.com

Report Coverage:

1. Executive summary

2. Scope of the report

3. Market research methodology

4. Introduction

5. Overview of ADCs

6. Pipeline portfolio

7. Market landscape

8. Market segmentation by MOA

9. Geographical segmentation

10. Market drivers

11. Impact of driversFor more details regarding Report coverage see the last slide

All logos and Images mentioned on this slide belong to their respective owners.

Page 8: Global Antibody Conjugates Drugs Market 2016 - 2020

www.MarketResearchReports.com

Report Coverage: Continues…

12. Market segmentation by technologies used in ADCs

13. Market challenges

14. Impact of drivers and challenges

15. Market trends

16. Vendor landscape

17. Appendix

For more details regarding Report coverage see the last slide

All logos and Images mentioned on this slide belong to their respective owners.

Page 9: Global Antibody Conjugates Drugs Market 2016 - 2020

www.MarketResearchReports.com

Company Coverage: (Partial List) 1. F. Hoffmann-La Roche AG2. Seattle Genetics Inc.3. Takeda Pharmaceutical Company4. AbbVie5. AbGenomics6. ADC Therapeutics7. Agensys8. ALMAC Group9. Ambrx10. Astellas Pharma11. AstraZeneca12. Bayer HealthCare13. Celldex Therapeutics

For more details regarding Report coverage see the last slideAll logos and Images mentioned on this slide belong to their respective owners.

Page 10: Global Antibody Conjugates Drugs Market 2016 - 2020

www.MarketResearchReports.com

Custom Research: Are you an industry professional, entrepreneur,

venture capitalist, investors and organization, then let us know your specific research requirements. Our goal is to cater to your requirements be it for a custom market research project, syndicated research report on a specific market or industry sector, newsletter creation, case study development or anything else related to marketing research.

For Any Customization Related query Visit IdeaCenter @http://www.marketresearchreports.com/idea-center

For regular industry updates subscribe to our newsletter at: http://www.marketresearchreports.com/subscribe-to-newsletter

Page 11: Global Antibody Conjugates Drugs Market 2016 - 2020

www.MarketResearchReports.com

How To Buy This Report?Visit following URL to see Table of Content and purchase this publication:

http://mrr.cm/Jqq

About Market Research Reports, Inc.Market Research Reports provides a customized set of reports from reputed Publishers, built on the intelligence available within organizations and leverages on our motto of “Intelligence Redefined”.

Contact : Mr. Sudeep ChakravartyEmail : [email protected]: +1 302-703-7787 (USA) +91-8762746600 (India)